Aberdeen Group’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$879K	Buy	+78,380	New	+$879K	﹤0.01%	839
2024 Q3	–	Sell	-2,705	Closed	-$124K	–	974
2024 Q2	$124K	Hold	2,705	–	–	﹤0.01%	937
2024 Q1	$57.1K	Hold	2,705	–	–	﹤0.01%	942
2023 Q4	$55.2K	Buy	+2,705	New	+$55.2K	﹤0.01%	956